Wall Street analyst estimates for Milestone Scientific Inc. (MLSS): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.01 | ||
| 2026-08-13 | $-0.01 | $-0.01 | +0.0% |
| 2026-05-13 | $-0.01 | $-0.01 | +33.3% |
| 2026-03-31 | $-0.02 | $-0.01 | -33.3% |
| 2025-11-13 | $-0.01 | $-0.01 | +33.3% |
| 2025-08-14 | $-0.02 | $-0.01 | -100.0% |
| 2025-05-15 | $-0.02 | $-0.01 | -100.0% |
| 2025-03-28 | $-0.03 | $-0.01 | -155.1% |
Valuation Ratios
| Price / Book | 9.56 |
| EV / EBITDA | -9.00 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.5M | $11.3M | $9.6M | $8.4M | $5.4M | $10.3M | $8.8M | $9.8M | $8.6M | $9.0M |
| Cost of Revenue | $4.2M | $4.3M | $5.2M | $2.7M | $1.8M | $4.0M | $3.9M | $3.0M | $2.2M | $2.6M |
| Gross Profit | $6.3M | $7.0M | $4.4M | $5.7M | $3.6M | $6.3M | $4.9M | $6.8M | $6.4M | $6.3M |
| Research & Development | $1.3M | $272746 | $245636 | $189923 | $307850 | $878210 | $1.2M | $701378 | $858767 | $449469 |
| Selling, General & Admin | $11.5M | $11.9M | $10.6M | $9.5M | 0 | 0 | 0 | 0 | 0 | $11.6M |
| Operating Expenses | $12.8M | $12.2M | $10.9M | $9.7M | $11.1M | $13.7M | $13.7M | $13.9M | $13.2M | $12.0M |
| Operating Income | -$6.5M | -$5.2M | -$8.0M | -$4.0M | -$7.5M | -$7.4M | -$8.8M | -$7.1M | -$6.8M | -$5.7M |
| EBITDA | -$6.4M | -$4.7M | -$5.6M | -$7.4M | -$7.4M | -$6.8M | -$8.7M | -$6.9M | -$4.7M | -$5.5M |
| Interest Expense | 0 | 0 | 0 | 0 | $18081 | $16360 | 0 | 0 | 0 | $25599 |
| Pre-tax Income | -$6.5M | -$5.2M | -$8.0M | -$7.6M | -$7.4M | -$6.9M | -$8.8M | -$7.0M | -$4.7M | -$5.7M |
| Income Tax | -$19101 | $19093 | $23986 | $18126 | $15500 | $333 | 0 | 0 | 0 | 0 |
| Net Income | -$5.9M | -$5.2M | -$7.4M | -$7.5M | -$7.3M | -$6.8M | -$8.7M | -$6.9M | -$4.7M | -$5.7M |
| EPS | $-0.22 | $-0.16 | $-0.21 | $-0.17 | $-0.12 | $-0.10 | $-0.12 | $-0.10 | $-0.06 | $-0.07 |
| EPS (Diluted) | $-0.22 | $-0.16 | $-0.21 | $-0.17 | $-0.12 | $-0.10 | $-0.12 | $-0.10 | $-0.06 | $-0.07 |
| Shares Outstanding (Diluted) | $27.0M | $32.7M | $35.3M | $45.7M | $63.1M | $68.8M | $70.6M | $72.8M | $79.8M | $82.1M |
Price
| Price | $0.40 |
| Market Cap | $35M |
| Exchange | AMEX |
| Country | US |
Related companies: APUS · HBIO · IGC · MIRA · MYO · NTRB · NXGL
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of MLSS: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks